Similar articles

• Implications for clinical treatment from the micrometer site dosimetric calculations in boron neutron capture therapy.

  Nichols TL, Kabalka GW, Miller LF, McCormack MT, Johnson A. Nichols TL, et al. Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S161-3. doi: 10.1016/j.apradiso.2009.03.039. Epub 2009 Mar 27. Appl Radiat Isot. 2009. PMID: 19375932
• Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

  Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT; Swedish Brain Tumour Study Group. Henriksson R, et al. Radiother Oncol. 2008 Aug;88(2):183-91. doi: 10.1016/j.radonc.2006.04.015. Epub 2008 Mar 11. Radiother Oncol. 2008. PMID: 18336940 Clinical Trial.
• Prediction of boron concentrations in blood from patients on boron neutron capture therapy.

  Shibata Y, Matsumura A, Yamamoto T, Akutsu H, Yasuda S, Nakai K, Nose T, Yamamoto K, Kumada H, Hori N, Ohtake S. Shibata Y, et al. Anticancer Res. 2003 Nov-Dec;23(6D):5231-5. Anticancer Res. 2003. PMID: 14981995
• Boron neutron capture therapy for glioblastoma.

  Yamamoto T, Nakai K, Matsumura A. Yamamoto T, et al. Cancer Lett. 2008 Apr 18;262(2):143-52. doi: 10.1016/j.canlet.2008.01.021. Epub 2008 Mar 4. Cancer Lett. 2008. PMID: 18313207 Review.
• Boron neutron capture therapy for the treatment of glioblastomas and extracranial tumours: as effective, more effective or less effective than photon irradiation?

  Barth RF, Joensuu H. Barth RF, et al. Radiother Oncol. 2007 Feb;82(2):119-22. doi: 10.1016/j.radonc.2007.01.010. Epub 2007 Feb 8. Radiother Oncol. 2007. PMID: 17291613 Review. No abstract available.